Gardasil Vaccine

From the web site www.sailhome.org - an excellent site

The CDC claims human papilloma viruses (HPV) alter cells, ultimately triggering cancers of the cervix and genitalia.

HPV is not the only potential source for these cancers. Validating the actual cause of these cancers is difficult. The only way to detect the presence of HPV in women is through a special DNA test. Only a small number of women will ever acquire cervical cancer traceable to HPV. Regular Pap testing remains the best means for identifying cervical cancer regardless of origin.

There are over 100 HPV strains. Approximately 30 of them are transmitted sexually. In rare circumstances, 10 of these might precipitate cancer. Gardasil targets 4 viruses presumed to cause 70% of these rare cancer cases.

The vaccine has not been proven to actually prevent cancer. The vaccine does not prevent the transfer of sexually transmitted diseases (STD). Most women who get HPV clear it from their systems naturally.

Gardasil vaccine is injected 3 times over a 6 month period. Along with other chemicals contained in the vaccine, recipients will receive a total of 675 µg aluminum, 150 µg polysorbate 80, and 105 µg sodium borate.

Each individual dose of Gardasil contains 225 µg aluminum. An 11-year old female in the 50th percentile weighs 37 kg.

Unit conversion yields


There is no safety standard for injected aluminum.

However, using the National Secondary Drinking Water standard for aluminum of 0.05 mg/L (50 ppb) shows that the child's toxic exposure to aluminum is 120x over that limit.

Using the 5 ppb threshold listed under Warnings in this insert for vitamin K injections puts aluminum exposure from a single dose of Gardasil at 1200x over that limit.

This exposure will happen 3 times during 6 months. The burden will be significantly worse if other vaccines are taken into consideration.

This document analyzes adverse events associated with Gardasil as recorded in the VAERS database. Lowlights include

• Unusually high rates of fainting shortly after administration.
• 
  
• Rapidly increasing cases of Guillain-Barre Syndrome (GBS) -- a disease where the body's immune system attacks the peripheral nervous system resulting in numbness and tingling, decreased sensation in the hands and feet, weakness and difficulty walking, and in some cases paralysis.
• 
  
• Life-threatening challenge-rechallenge reactions.
• 
  
• Over 80 percent of Gardasil adverse event reports to VAERS involve co-administration with one or more vaccines. Toxic synergy at work. There is no empirical evidence to show that giving Gardasil in combination with any other vaccine is safe. Co-administration with Menactra appears to be especially risky.

???????????????????????????????????????????????????????????????????????????????????

It is important to note that during clinical trials of Gardasil more than 90% of the 'placebo' subjects received an aluminum-containing placebo.

This obscures the true rate of adverse experiences because aluminum is toxic.

So for example, instead of of the rate of fever in vaccinated vs. unvaccinated being 16% higher, it is more like 1400% higher. Gardasil increases the rate of vomiting not by 25%, but more like 1500%. Using the toxic placebo during trials makes Gardasil appear to be safer than it really is.

Even with that egregious tweaking, trial outcomes still show that the majority of people injected with Gardasil experienced adverse events.

Readers should be especially cautious when interpreting Merck's outcomes for events such as pregnancy-related medical problems and birth defects. By May 11, 2007, of the 42 women who received Gardasil while pregnant, 18 experienced side effects ranging from spontaneous abortion to fetal abnormalities.